Skip to main content
. 2007 May;41(5):335–336. doi: 10.1136/bjsm.2006.030585

Table 1 Drug regimen.

Week
1 2 3 4 5 6 7 8 9 10 11 12 13
Growth hormone 4 IU per day 8 IU per day
Insulin 8 iu per day
Testosterone propionate 1000 mg per week 1000 mg per week
Deca durabolin 800 mg per week 600 mg per week
Oxymethalone 100 mg per day
methandrostenolone 100 mg per day
Testosterone enanthate 1000 mg per week 800 mg per week
Liothyronine sodium 50–200 μg per day
Boldenone dndecylenate 600 mg per week
Clenbuterol hydrochloride 240 μg per day
Fluoxymesterone 20 mg per day 20 mg per day
Mesterolone 100 mg per day
Anastrazole 1 mg per day
Stanozolol 10 mg per day
Trenbelone acetate 100 mg per day
Spironolactone 10
β‐HCG 2500 IU three times a week 2500 IU three times a week 2500 μ three times a week

Anastrazole, a non‐steroidal aromatase inhibitor, blocks the peripheral conversion of testosterone to oestrogen, thus reducing feminising side effects such as gynaecomastia.

β‐HCG, β‐human chorionic gonadotropin, β‐HCG was used to limit the hypogonadatrophic effects of exogenous testosterone.